🇺🇸 FDA
Patent

US 11564954

Tumor-delivered multi-target therapeutics for colon cancer

granted A61KA61K35/74A61P

Quick answer

US patent 11564954 (Tumor-delivered multi-target therapeutics for colon cancer) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K35/74, A61P, A61P35/04